SANUWAVE Health said its shareholders approved the proposed business combination with SEP Acquisition. More than 99% of the votes cast were in favor of the deal.
The SPAC’s shareholders approved the acquisition in January.
The deal was announced last August at an enterprise value of $127.5 million.
SANUWAVE is a provider of next-generation FDA-approved wound care products.
The SPAC has lost just over 95% of its shares to redemptions on extensions since its $170 million IPO in July 2021. Formerly Mercury Ecommerce Acquisition, the SPAC was renamed in January 2023. Read more.
